Global and United States Hospital-acquired infections (HAIs) Control Market Report & Forecast 2023-2028

Report ID: 1859146 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Hospital-acquired infections (HAIs) Control Revenue in Hospital-acquired infections (HAIs) Control Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Hospital-acquired infections (HAIs) Control Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Hospital-acquired infections (HAIs) Control Market Size for the Year 2017-2028
        1.2.2 Global Hospital-acquired infections (HAIs) Control Market Size for the Year 2017-2028
    1.3 Hospital-acquired infections (HAIs) Control Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Hospital-acquired infections (HAIs) Control in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Hospital-acquired infections (HAIs) Control Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Hospital-acquired infections (HAIs) Control Market Dynamics
        1.4.1 Hospital-acquired infections (HAIs) Control Industry Trends
        1.4.2 Hospital-acquired infections (HAIs) Control Market Drivers
        1.4.3 Hospital-acquired infections (HAIs) Control Market Challenges
        1.4.4 Hospital-acquired infections (HAIs) Control Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Hospital-acquired infections (HAIs) Control by Type
    2.1 Hospital-acquired infections (HAIs) Control Market Segment by Type
        2.1.1 Diagnostic techniques
        2.1.2 Dleaning and sterilization
        2.1.3 Treatment
    2.2 Global Hospital-acquired infections (HAIs) Control Market Size by Type (2017, 2022 & 2028)
    2.3 Global Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2028)
    2.4 United States Hospital-acquired infections (HAIs) Control Market Size by Type (2017, 2022 & 2028)
    2.5 United States Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2028)
3 Hospital-acquired infections (HAIs) Control by Application
    3.1 Hospital-acquired infections (HAIs) Control Market Segment by Application
        3.1.1 General Hospital
        3.1.2 Infectious Disease Hospital
    3.2 Global Hospital-acquired infections (HAIs) Control Market Size by Application (2017, 2022 & 2028)
    3.3 Global Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2028)
    3.4 United States Hospital-acquired infections (HAIs) Control Market Size by Application (2017, 2022 & 2028)
    3.5 United States Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2028)
4 Global Hospital-acquired infections (HAIs) Control Competitor Landscape by Company
    4.1 Global Hospital-acquired infections (HAIs) Control Market Size by Company
        4.1.1 Top Global Hospital-acquired infections (HAIs) Control Companies Ranked by Revenue (2021)
        4.1.2 Global Hospital-acquired infections (HAIs) Control Revenue by Player (2017-2022)
    4.2 Global Hospital-acquired infections (HAIs) Control Concentration Ratio (CR)
        4.2.1 Hospital-acquired infections (HAIs) Control Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Hospital-acquired infections (HAIs) Control in 2021
        4.2.3 Global Hospital-acquired infections (HAIs) Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Hospital-acquired infections (HAIs) Control Headquarters, Revenue in Hospital-acquired infections (HAIs) Control Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Hospital-acquired infections (HAIs) Control Headquarters and Area Served
        4.3.2 Global Hospital-acquired infections (HAIs) Control Companies Revenue in Hospital-acquired infections (HAIs) Control Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Hospital-acquired infections (HAIs) Control Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Hospital-acquired infections (HAIs) Control Market Size by Company
        4.5.1 Top Hospital-acquired infections (HAIs) Control Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Hospital-acquired infections (HAIs) Control Revenue by Players (2020, 2021 & 2022)
5 Global Hospital-acquired infections (HAIs) Control Market Size by Region
    5.1 Global Hospital-acquired infections (HAIs) Control Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Hospital-acquired infections (HAIs) Control Market Size by Region (2017-2028)
        5.2.1 Global Hospital-acquired infections (HAIs) Control Market Size by Region: 2017-2022
        5.2.2 Global Hospital-acquired infections (HAIs) Control Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Hospital-acquired infections (HAIs) Control Market Size YoY Growth 2017-2028
        6.1.2 North America Hospital-acquired infections (HAIs) Control Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Hospital-acquired infections (HAIs) Control Market Size YoY Growth 2017-2028
        6.3.2 Europe Hospital-acquired infections (HAIs) Control Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Hospital-acquired infections (HAIs) Control Market Size YoY Growth 2017-2028
        6.4.2 Latin America Hospital-acquired infections (HAIs) Control Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Hospital-acquired infections (HAIs) Control Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Hospital-acquired infections (HAIs) Control Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 STERIS Corporation
        7.1.1 STERIS Corporation Company Details
        7.1.2 STERIS Corporation Business Overview
        7.1.3 STERIS Corporation Hospital-acquired infections (HAIs) Control Introduction
        7.1.4 STERIS Corporation Revenue in Hospital-acquired infections (HAIs) Control Business (2017-2022)
        7.1.5 STERIS Corporation Recent Development
    7.2 Advanced Sterilization Products Division
        7.2.1 Advanced Sterilization Products Division Company Details
        7.2.2 Advanced Sterilization Products Division Business Overview
        7.2.3 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Introduction
        7.2.4 Advanced Sterilization Products Division Revenue in Hospital-acquired infections (HAIs) Control Business (2017-2022)
        7.2.5 Advanced Sterilization Products Division Recent Development
    7.3 Hoffmann-La Roche
        7.3.1 Hoffmann-La Roche Company Details
        7.3.2 Hoffmann-La Roche Business Overview
        7.3.3 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Introduction
        7.3.4 Hoffmann-La Roche Revenue in Hospital-acquired infections (HAIs) Control Business (2017-2022)
        7.3.5 Hoffmann-La Roche Recent Development
    7.4 Pfizer
        7.4.1 Pfizer Company Details
        7.4.2 Pfizer Business Overview
        7.4.3 Pfizer Hospital-acquired infections (HAIs) Control Introduction
        7.4.4 Pfizer Revenue in Hospital-acquired infections (HAIs) Control Business (2017-2022)
        7.4.5 Pfizer Recent Development
    7.5 Becton Dickinson
        7.5.1 Becton Dickinson Company Details
        7.5.2 Becton Dickinson Business Overview
        7.5.3 Becton Dickinson Hospital-acquired infections (HAIs) Control Introduction
        7.5.4 Becton Dickinson Revenue in Hospital-acquired infections (HAIs) Control Business (2017-2022)
        7.5.5 Becton Dickinson Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Hospital-acquired infections (HAIs) Control Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Hospital-acquired infections (HAIs) Control Market Trends
    Table 3. Hospital-acquired infections (HAIs) Control Market Drivers
    Table 4. Hospital-acquired infections (HAIs) Control Market Challenges
    Table 5. Hospital-acquired infections (HAIs) Control Market Restraints
    Table 6. Global Hospital-acquired infections (HAIs) Control Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Hospital-acquired infections (HAIs) Control Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Hospital-acquired infections (HAIs) Control Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Hospital-acquired infections (HAIs) Control Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Hospital-acquired infections (HAIs) Control Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Hospital-acquired infections (HAIs) Control Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Hospital-acquired infections (HAIs) Control Revenue Share by Player, 2017-2022
    Table 13. Global Hospital-acquired infections (HAIs) Control Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Hospital-acquired infections (HAIs) Control by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-acquired infections (HAIs) Control as of 2021)
    Table 15. Top Players of Hospital-acquired infections (HAIs) Control in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Hospital-acquired infections (HAIs) Control Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Hospital-acquired infections (HAIs) Control Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Hospital-acquired infections (HAIs) Control Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Hospital-acquired infections (HAIs) Control Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Hospital-acquired infections (HAIs) Control Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Hospital-acquired infections (HAIs) Control Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Hospital-acquired infections (HAIs) Control Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Hospital-acquired infections (HAIs) Control Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Hospital-acquired infections (HAIs) Control Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Hospital-acquired infections (HAIs) Control Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Hospital-acquired infections (HAIs) Control Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Hospital-acquired infections (HAIs) Control Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. STERIS Corporation Company Details
    Table 31. STERIS Corporation Business Overview
    Table 32. STERIS Corporation Hospital-acquired infections (HAIs) Control Product
    Table 33. STERIS Corporation Revenue in Hospital-acquired infections (HAIs) Control Business (2017-2022) & (US$ Million)
    Table 34. STERIS Corporation Recent Development
    Table 35. Advanced Sterilization Products Division Company Details
    Table 36. Advanced Sterilization Products Division Business Overview
    Table 37. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product
    Table 38. Advanced Sterilization Products Division Revenue in Hospital-acquired infections (HAIs) Control Business (2017-2022) & (US$ Million)
    Table 39. Advanced Sterilization Products Division Recent Development
    Table 40. Hoffmann-La Roche Company Details
    Table 41. Hoffmann-La Roche Business Overview
    Table 42. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product
    Table 43. Hoffmann-La Roche Revenue in Hospital-acquired infections (HAIs) Control Business (2017-2022) & (US$ Million)
    Table 44. Hoffmann-La Roche Recent Development
    Table 45. Pfizer Company Details
    Table 46. Pfizer Business Overview
    Table 47. Pfizer Hospital-acquired infections (HAIs) Control Product
    Table 48. Pfizer Revenue in Hospital-acquired infections (HAIs) Control Business (2017-2022) & (US$ Million)
    Table 49. Pfizer Recent Development
    Table 50. Becton Dickinson Company Details
    Table 51. Becton Dickinson Business Overview
    Table 52. Becton Dickinson Hospital-acquired infections (HAIs) Control Product
    Table 53. Becton Dickinson Revenue in Hospital-acquired infections (HAIs) Control Business (2017-2022) & (US$ Million)
    Table 54. Becton Dickinson Recent Development
    Table 55. Research Programs/Design for This Report
    Table 56. Key Data Information from Secondary Sources
    Table 57. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hospital-acquired infections (HAIs) Control Product Picture
    Figure 2. Global Hospital-acquired infections (HAIs) Control Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Hospital-acquired infections (HAIs) Control Market Size 2017-2028 (US$ Million)
    Figure 4. United States Hospital-acquired infections (HAIs) Control Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Hospital-acquired infections (HAIs) Control Market Size 2017-2028 (US$ Million)
    Figure 6. United States Hospital-acquired infections (HAIs) Control Market Share in Global 2017-2028
    Figure 7. Hospital-acquired infections (HAIs) Control Report Years Considered
    Figure 8. Product Picture of Diagnostic techniques
    Figure 9. Product Picture of Dleaning and sterilization
    Figure 10. Product Picture of Treatment
    Figure 11. Global Hospital-acquired infections (HAIs) Control Market Share by Type in 2022 & 2028
    Figure 12. Global Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Hospital-acquired infections (HAIs) Control Market Share by Type (2017-2028)
    Figure 14. United States Hospital-acquired infections (HAIs) Control Market Share by Type in 2022 & 2028
    Figure 15. United States Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Hospital-acquired infections (HAIs) Control Market Share by Type (2017-2028)
    Figure 17. Product Picture of General Hospital
    Figure 18. Product Picture of Infectious Disease Hospital
    Figure 19. Global Hospital-acquired infections (HAIs) Control Market Share by Application in 2022 & 2028
    Figure 20. Global Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Hospital-acquired infections (HAIs) Control Market Share by Application (2017-2028)
    Figure 22. United States Hospital-acquired infections (HAIs) Control Market Share by Application in 2022 & 2028
    Figure 23. United States Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Hospital-acquired infections (HAIs) Control Market Share by Application (2017-2028)
    Figure 25. North America Hospital-acquired infections (HAIs) Control Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Hospital-acquired infections (HAIs) Control Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Hospital-acquired infections (HAIs) Control Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. UAE Hospital-acquired infections (HAIs) Control Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. STERIS Corporation Revenue Growth Rate in Hospital-acquired infections (HAIs) Control Business (2017-2022)
    Figure 54. Advanced Sterilization Products Division Revenue Growth Rate in Hospital-acquired infections (HAIs) Control Business (2017-2022)
    Figure 55. Hoffmann-La Roche Revenue Growth Rate in Hospital-acquired infections (HAIs) Control Business (2017-2022)
    Figure 56. Pfizer Revenue Growth Rate in Hospital-acquired infections (HAIs) Control Business (2017-2022)
    Figure 57. Becton Dickinson Revenue Growth Rate in Hospital-acquired infections (HAIs) Control Business (2017-2022)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
STERIS Corporation
Advanced Sterilization Products Division
Hoffmann-La Roche
Pfizer
Becton Dickinson
Frequently Asked Questions
Hospital-acquired infections (HAIs) Control report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hospital-acquired infections (HAIs) Control report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hospital-acquired infections (HAIs) Control report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cat Treats

Cat Treats market is segmented by region (country), players, by Type and by Application. Players, ... Read More

Lampholder

Lampholder market is segmented by region (country), players, by Type and by Application. Players, ... Read More

Membrane Technology

Membrane Technology market is segmented by region (country), players, by Type and by Application. ... Read More